Home / Netherlands / Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
689 disclosures on record
Evolution of the disclosed total
0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
July 31, 2015 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 28, 2023 | Qube Research & Technologies Ltd. | 0.60% | still open |
| June 15, 2023 | Qube Research & Technologies Ltd. | 0.59% | still open |
| June 12, 2023 | Arrowstreet Capital, Limited Partnership | 1.60% | still open |
| May 31, 2023 | Arrowstreet Capital, Limited Partnership | 1.50% | still open |
| May 30, 2023 | AHL Partners LLP | 0.50% | still open |
| May 24, 2023 | Arrowstreet Capital, Limited Partnership | 1.40% | still open |
| May 19, 2023 | Arrowstreet Capital, Limited Partnership | 1.30% | still open |
| May 19, 2023 | Marshall Wace LLP | 0.49% | still open |
| May 16, 2023 | Qube Research & Technologies Ltd. | 0.60% | still open |
| May 12, 2023 | Qube Research & Technologies Ltd. | 0.59% | still open |
| May 11, 2023 | Marshall Wace LLP | 0.50% | still open |
| May 9, 2023 | Qube Research & Technologies Ltd. | 0.60% | still open |
| May 5, 2023 | Arrowstreet Capital, Limited Partnership | 1.20% | still open |
| May 4, 2023 | Arrowstreet Capital, Limited Partnership | 1.11% | still open |
| May 1, 2023 | Qube Research & Technologies Ltd. | 0.51% | still open |
| April 28, 2023 | Arrowstreet Capital, Limited Partnership | 1.02% | still open |
| April 28, 2023 | Qube Research & Technologies Ltd. | 0.49% | still open |
| April 27, 2023 | Arrowstreet Capital, Limited Partnership | 0.91% | still open |
| April 26, 2023 | Qube Research & Technologies Ltd. | 0.52% | still open |
| April 20, 2023 | Arrowstreet Capital, Limited Partnership | 0.84% | still open |
| April 5, 2023 | Arrowstreet Capital, Limited Partnership | 0.71% | still open |
| March 30, 2023 | Qube Research & Technologies Ltd. | 0.49% | still open |
| March 29, 2023 | Arrowstreet Capital, Limited Partnership | 0.61% | still open |
| March 24, 2023 | Arrowstreet Capital, Limited Partnership | 0.52% | still open |
| March 16, 2023 | Qube Research & Technologies Ltd. | 0.50% | still open |
| January 13, 2023 | AHL Partners LLP | 0.49% | still open |
| December 20, 2022 | AHL Partners LLP | 0.50% | still open |
| December 15, 2022 | AHL Partners LLP | 0.49% | still open |
| December 12, 2022 | AHL Partners LLP | 0.50% | still open |
| November 29, 2022 | AHL Partners LLP | 0.49% | still open |
| November 28, 2022 | AQR Capital Management, LLC | 0.49% | still open |
| October 25, 2022 | AQR Capital Management, LLC | 0.51% | still open |
| September 8, 2022 | AQR Capital Management, LLC | 0.49% | still open |
| August 25, 2022 | AQR Capital Management, LLC | 0.50% | still open |
| August 5, 2022 | AQR Capital Management, LLC | 0.49% | still open |
| July 29, 2022 | AHL Partners LLP | 0.59% | still open |
| June 23, 2022 | AQR Capital Management, LLC | 0.50% | still open |
| April 5, 2022 | Marshall Wace LLP | 0.47% | still open |
| April 1, 2022 | AHL Partners LLP | 0.69% | still open |
| March 30, 2022 | Marshall Wace LLP | 0.58% | still open |
| March 23, 2022 | AQR Capital Management, LLC | 0.49% | still open |
| March 16, 2022 | AQR Capital Management, LLC | 0.50% | still open |
| March 4, 2022 | Marshall Wace LLP | 0.69% | still open |
| February 28, 2022 | Qube Research & Technologies Ltd. | 0.49% | still open |
| February 23, 2022 | Marshall Wace LLP | 0.71% | still open |
| February 10, 2022 | Marshall Wace LLP | 0.63% | still open |
| February 7, 2022 | Marshall Wace LLP | 0.51% | still open |
| February 3, 2022 | Qube Research & Technologies Ltd. | 0.53% | still open |
| February 1, 2022 | Qube Research & Technologies Ltd. | 0.45% | still open |
| January 31, 2022 | Qube Research & Technologies Ltd. | 0.70% | still open |
Other companies sold short in the Netherlands
- Signify N.V. 10.49% of the capital sold short
- Akzo Nobel N.V. 8.27% of the capital sold short
- Pharming Group N.V. 8.18% of the capital sold short
- Imcd N.V. 5.61% of the capital sold short
- Basic-Fit N.V. 4.23% of the capital sold short
- Fugro N.V. 4.13% of the capital sold short
- DSM-Firmenich AG 3.65% of the capital sold short
- PostNL N.V. 2.55% of the capital sold short
- Alfen N.V. 2.31% of the capital sold short
- Shell plc 2.05% of the capital sold short
- The Magnum Ice Cream Company N.V. 1.77% of the capital sold short
- Arcadis N.V. 1.76% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=3